Metabolism

Tumour Microenvironment

Artificial Intelligence and Machine Learning

I lead a systems biology lab funded by the European Research Council and Cancer Research UK.

We develop and apply advanced computational, machine learning and mathematical modelling approaches to the analysis of cutting edge multi-omics data to understand cancer as a complex system.

Some of our main projects are:

• Agent Based Modelling of Gene Networks to model disease-host interaction
• Network analysis to study gene expression regulation and cell-cell signalling
• Machine learning methods to derive integrated multi-omics classifiers
• Developing and using omics 'signatures' to infer functional and phenotypic status
• Integration of functional (CRISPR) and omics (RNAseq) assays to dissect molecular circuits
  

After a Masters Degree in Theoretical Physics from the University of Turin, I completed a PhD in Physics and Mathematical Modelling at the Institute of Cancer Research, University of London. I undertook postdoctoral research in anaysis of imaging data at the ICR, and then joined the Statistics Group at the Gray Cancer Institute and the MRC Clinical Trials Unit, London, to work on biomarker research studies. Following this, I joined the Medical Sciences Division, University of Oxford, first as a postdoctoral research fellow in systems biology, and then as Principal Investigator and Head of the Computational Biology and Integrative Genomics Lab.

In addition to my research work, I teach post-graduate courses, including the new MSc in Precision Cancer Medicine, where I lead the Omics module, and the MSc in Radiation Biology, where I teach Statistics and Computational methods applied to Omics. I also teach at national and international Masters Courses and Advanced Schools, including Statistics and Bioinformatics in the MSc courses at the University of Tsukuba, Japan, and at the Advanced Courses at the Wellcome Genome Campus, University of Cambridge, UK.

I serve on several national and international committees, including funding agencies Horizon2020, the European Research Council, the Medical Research Council, the UK Research Institute and Cancer Research UK. And I am member of governative evaluation panels, including service as member of the Biological Science Panel and Interdisciplinary Advisor for the REF-2021.

I authored over 130 publications, several in high impact journals (Google Scholar, ORCID), and and I am recipient of a Cancer Research UK Programme and European Research Council Programme Award.

Group Members